Page 25 - Michael Erman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(Reuters) -U.S. intelligence officials in late February told senators working on a biotech security bill that Chinese pharmaceutical firm WuXi AppTec had transferred U.S. intellectual property to Beijing without consent, according to two sources. The U.S. government is concerned that certain Chinese biotech companies are contributing technology or research and development for use by China's military, and the proposed legislation would restrict U.S. government funds going to those Chinese companies. The classified briefing to about a dozen senators was led by the FBI, the State Departmen...

A WuXi AppTec spokesperson said: "We are not aware of any unauthorized transfers by WuXi AppTec of any U.S. client's data or intellectual property to China. Safeguarding our customers' information is of the utmost importance to us, and we store it in keeping with their direction."

The U.S. Food and Drug Administration on Tuesday approved Merck's treatment for adults with high blood pressure due to constriction of lung arteries, adding another...

The U.S. FDA on Tuesday approved Merck's treatment for adults with high blood pressure due to constriction of lung arteries, adding another potential blockbuster drug to the pharmaceutical giant's...

(This March 26 story has been corrected to remove reference to follicle-stimulating hormone, in paragraph 8) By Leroy Leo and Michael Erman (Reuters) - ...